Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Testing effectiveness (Phase 2)Study completedNCT03719690
What this trial is testing

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Who this might be right for
HRAS Gene MutationHNSCC
Kura Oncology, Inc. 296
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756190
What this trial is testing

Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06681285
What this trial is testing

Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)

Who this might be right for
Esophageal Carcinoma
Hebei Medical University Fourth Hospital 51
Large-scale testing (Phase 3)Looking for participantsNCT06601335
What this trial is testing

AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Akeso 510
Not applicableLooking for participantsNCT07187297
What this trial is testing

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Who this might be right for
WrinkleLax SkinLines Skin
Bausch Health Americas, Inc. 164
Testing effectiveness (Phase 2)UnknownNCT03424291
What this trial is testing

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT04428333
What this trial is testing

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT06557889
What this trial is testing

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Institut Claudius Regaud 86
Testing effectiveness (Phase 2)Looking for participantsNCT06469944
What this trial is testing

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)UnknownNCT04999800
What this trial is testing

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shi Yuankai 20
Testing effectiveness (Phase 2)UnknownNCT05075122
What this trial is testing

Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Martin-Luther-Universität Halle-Wittenberg 75
Not applicableStudy completedNCT06897826
What this trial is testing

Effect of Hamstring Stretching on Cervical Flexor Muscle Endurance

Who this might be right for
Healthy
Abant Izzet Baysal University 66
Testing effectiveness (Phase 2)UnknownNCT05179317
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)WithdrawnNCT04806945
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Shanghai Henlius Biotech
Large-scale testing (Phase 3)Active Not RecruitingNCT06459180
What this trial is testing

Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 686
Testing effectiveness (Phase 2)UnknownNCT04063683
What this trial is testing

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487702
What this trial is testing

A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Rui-hua Xu, MD, PhD 70
Not applicableStudy completedNCT03305302
What this trial is testing

Isolation and Establishment of Gustatory Cell Lines in Patients Operated on for Cancer of the Mobile Tongue - ImmortTasteCELL

Who this might be right for
Cancer of the Tongue
Centre Hospitalier Universitaire Dijon 50
Testing effectiveness (Phase 2)Study completedNCT01264328
What this trial is testing

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 40
Next Page